Hjem › Aplastisk anæmi › Maryland
Aplastisk anæmi kliniske forsøg i Maryland
10 studier for Aplastisk anæmi søger deltagere på steder i Maryland.
Byer i Maryland
Officiel studietekst (engelsk)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1/2
Alder 12 til 120 · Alle køn · Opdateret 2. okt. 2026 · NCT06303193Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1/2
Alder 4 til 75 · Alle køn · Opdateret 1. okt. 2026 · NCT03173937Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudie
Alder 2 til 99 · Alle køn · Opdateret 30. sep. 2026 · NCT05012111Cancer in Inherited Bone Marrow Failure Syndromes
- National Institutes of Health Clinical Center, Bethesda
- National Cancer Institute - Shady Grove, Rockville
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
1 Day – 100 Years · Alle køn · Opdateret 30. sep. 2026 · NCT00027274Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
RekruttererTidlig fase 1
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06398457Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 4 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT01174108Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 4 til 75 · Alle køn · Opdateret 8. sep. 2026 · NCT03520647A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Johns Hopkins, Baltimore
- Nih/Niaid, Bethesda
- Nih/Nhlbi, Bethesda
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT01351545Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 3 til 99 · Alle køn · Opdateret 9. mar. 2026 · NCT04304820Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
- Johns Hopkins University, Baltimore
RekruttererFase 2
Alder 3 til 75 · Alle køn · Opdateret 17. feb. 2026 · NCT06517641Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.